Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Aptorum Group Ltd (APM)

$7.00 +1.10% NASDAQ: APM · 15-min delayed
  • Public · NASDAQ: APM
  • 2 employees
$8.2MMarket cap
$431.4KRevenue · FY2023
-$1.4MNet income
2Employees
APMNASDAQ
2018IPO

About Aptorum Group Ltd

Aptorum Group Ltd is a clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. Aptorum's project pipeline includes SACT-1, a repurposed drug for the treatment of neuroblastoma, and ALS-4, a small molecule for the treatment of bacterial infections caused by Staphylococcus aureus, including but not limited to Methicillin-resistant Staphylococcus aureus (MRSA). Substantially all of the company's revenues are derived from within Hong Kong.

This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.

Reported figures

Financial summary

Revenue FY2023
$431.4K
Net income
-$1.4M
Total assets
$18.7M
Market cap
$8.2M

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: APM
$7.00 +1.10%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$6.92 $42.50

52-week range

Market cap
$8.2M
Shares outstanding
1.2M
Open
Day range
Prev close
Volume
IPO date
Dec 18, 2018

Aptorum Group Ltd (APM) Stock Price

  • Reported a net loss of $1.4M in FY2023.
  • Trading 84% below its 52-week high.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Aptorum Group Ltd.

Write a review
Newsroom

News about Aptorum Group Ltd

News & sentiment via Polygon.io

FAQ

Aptorum Group Ltd: frequently asked questions

Is Aptorum Group Ltd an American company?

Aptorum Group Ltd is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Aptorum Group Ltd publicly traded?

Yes — Aptorum Group Ltd is a publicly traded company. Its stock trades under the ticker symbol APM on the NASDAQ.

What does Aptorum Group Ltd do?

Aptorum Group Ltd is an American Medical Devices company in the Health & Beauty sector.

Explore

Similar companies

Browse all →